[1]
“The Cataylst Initiative: Innovative CME on Appropriate Use of Immunotherapy in the Systemic Treatment of Locally Advanced and Metastatic BCC and cSCC”, J of Skin, vol. 5, no. 6, p. s78, Nov. 2021, doi: 10.25251/skin.5.supp.78.